Literature DB >> 16368970

Phage library screening for the rapid identification and in vivo testing of candidate genes for a DNA vaccine against Mycoplasma mycoides subsp. mycoides small colony biotype.

John B March1, Catherine D Jepson, Jason R Clark, Makrina Totsika, Michael J Calcutt.   

Abstract

A new strategy for rapidly selecting and testing genetic vaccines has been developed, in which a whole genome library is cloned into a bacteriophage lambda ZAP Express vector which contains both prokaryotic (P(lac)) and eukaryotic (P(CMV)) promoters upstream of the insertion site. The phage library is plated on Escherichia coli cells, immunoblotted, and probed with hyperimmune and/or convalescent-phase antiserum to rapidly identify vaccine candidates. These are then plaque purified and grown as liquid lysates, and whole bacteriophage particles are then used directly to immunize the host, following which P(CMV)-driven expression of the candidate vaccine gene occurs. In the example given here, a semirandom genome library of the bovine pathogen Mycoplasma mycoides subsp. mycoides small colony (SC) biotype was cloned into lambda ZAP Express, and two strongly immunodominant clones, lambda-A8 and lambda-B1, were identified and subsequently tested for vaccine potential against M. mycoides subsp. mycoides SC biotype-induced mycoplasmemia. Sequencing and immunoblotting indicated that clone lambda-A8 expressed an isopropyl-beta-d-thiogalactopyranoside (IPTG)-inducible M. mycoides subsp. mycoides SC biotype protein with a 28-kDa apparent molecular mass, identified as a previously uncharacterized putative lipoprotein (MSC_0397). Clone lambda-B1 contained several full-length genes from the M. mycoides subsp. mycoides SC biotype pyruvate dehydrogenase region, and two IPTG-independent polypeptides, of 29 kDa and 57 kDa, were identified on immunoblots. Following vaccination, significant anti-M. mycoides subsp. mycoides SC biotype responses were observed in mice vaccinated with clones lambda-A8 and lambda-B1. A significant stimulation index was observed following incubation of splenocytes from mice vaccinated with clone lambda-A8 with whole live M. mycoides subsp. mycoides SC biotype cells, indicating cellular proliferation. After challenge, mice vaccinated with clone lambda-A8 also exhibited a reduced level of mycoplasmemia compared to controls, suggesting that the MSC_0397 lipoprotein has a protective effect in the mouse model when delivered as a bacteriophage DNA vaccine. Bacteriophage-mediated immunoscreening using an appropriate vector system offers a rapid and simple technique for the identification and immediate testing of putative candidate vaccines from a variety of pathogens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368970      PMCID: PMC1346666          DOI: 10.1128/IAI.74.1.167-174.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Bacterial viruses as human vaccines?

Authors:  Jason R Clark; John B March
Journal:  Expert Rev Vaccines       Date:  2004-08       Impact factor: 5.217

2.  Interferon production by T4 coliphage.

Authors:  W J Kleinschmidt; R J Douthart; E B Murphy
Journal:  Nature       Date:  1970-10-03       Impact factor: 49.962

3.  The actvity of mouse Kupffer cells following intravenous injection of T4 bacteriophage.

Authors:  C J Inchley
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

4.  The pyruvate dehydrogenase complex of Mycoplasma hyopneumoniae contains a novel lipoyl domain arrangement.

Authors:  Jake N Matic; Jody L Wilton; Rebecca J Towers; Anthony L Scarman; F Chris Minion; Mark J Walker; Steve P Djordjevic
Journal:  Gene       Date:  2003-11-13       Impact factor: 3.688

5.  Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle.

Authors:  Catherine D Jepson; John B March
Journal:  Vaccine       Date:  2004-06-23       Impact factor: 3.641

6.  Bacteriophage-mediated nucleic acid immunisation.

Authors:  Jason R Clark; John B March
Journal:  FEMS Immunol Med Microbiol       Date:  2004-01-15

7.  The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1T, the causative agent of contagious bovine pleuropneumonia (CBPP).

Authors:  Joakim Westberg; Anja Persson; Anders Holmberg; Alexander Goesmann; Joakim Lundeberg; Karl-Erik Johansson; Bertil Pettersson; Mathias Uhlén
Journal:  Genome Res       Date:  2004-02       Impact factor: 9.043

8.  Bacteriophages provide regulatory signals in mitogen-induced murine splenocyte proliferation.

Authors:  Michał Zimecki; Beata Weber-Dabrowska; Marzanna Łusiak-Szelachowska; Marian Mulczyk; Janusz Boratyński; Gryzelda Poźniak; Danuta Syper; Andrzej Górski
Journal:  Cell Mol Biol Lett       Date:  2003       Impact factor: 5.787

9.  Genetic immunisation against hepatitis B using whole bacteriophage lambda particles.

Authors:  John B March; Jason R Clark; Catherine D Jepson
Journal:  Vaccine       Date:  2004-04-16       Impact factor: 3.641

10.  Antigenic and genetic characterisation of lipoprotein lppC from Mycoplasma mycoides subsp. mycoides SC.

Authors:  Paola Pilo; Sandra Martig; Joachim Frey; Edy M Vilei
Journal:  Vet Res       Date:  2003 Nov-Dec       Impact factor: 3.683

View more
  9 in total

1.  Identification, bioinformatics analyses, and expression of immunoreactive antigens of Mycoplasma haemofelis.

Authors:  Joanne B Messick; Andrea P Santos
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

2.  Distinctive repertoire of contingency genes conferring mutation- based phase variation and combinatorial expression of surface lipoproteins in Mycoplasma capricolum subsp. capricolum of the Mycoplasma mycoides phylogenetic cluster.

Authors:  Kim S Wise; Mark F Foecking; Kerstin Röske; Young Jin Lee; Young Moo Lee; Anup Madan; Michael J Calcutt
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

3.  Proteomic profiling and identification of immunodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis.

Authors:  Vito G Delvecchio; Joseph P Connolly; Timothy G Alefantis; Alexander Walz; Marian A Quan; Guy Patra; John M Ashton; Jessica T Whittington; Ryan D Chafin; Xudong Liang; Paul Grewal; Akbar S Khan; Cesar V Mujer
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

4.  Immunoproteomic Analysis of Antibody Response of Rabbit Host Against Heat-Killed Francisella tularensis Live Vaccine Strain.

Authors:  Ritu Gaur; Syed Imteyaz Alam; Dev Vrat Kamboj
Journal:  Curr Microbiol       Date:  2017-02-23       Impact factor: 2.188

Review 5.  Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.

Authors:  Ali Dawood; Samah Attia Algharib; Gang Zhao; Tingting Zhu; Mingpu Qi; Kong Delai; Zhiyu Hao; Marawan A Marawan; Ihsanullah Shirani; Aizhen Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

6.  Multiplex screening of surface proteins from Mycoplasma mycoides subsp. mycoides small colony for an antigen cocktail enzyme-linked immunosorbent assay.

Authors:  Maja Neiman; Carl Hamsten; Jochen M Schwenk; Göran Bölske; Anja Persson
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

7.  Comparative proteomic analysis of Streptococcus suis biofilms and planktonic cells that identified biofilm infection-related immunogenic proteins.

Authors:  Yang Wang; Li Yi; Zongfu Wu; Jing Shao; Guangjin Liu; Hongjie Fan; Wei Zhang; Chengping Lu
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

8.  Identification of the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R.

Authors:  Xiankai Liu; Dongshu Wang; Jingxiao Ren; Chao Tong; Erling Feng; Xuefang Wang; Li Zhu; Hengliang Wang
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

9.  In vivo gene delivery and expression by bacteriophage lambda vectors.

Authors:  H A Lankes; C N Zanghi; K Santos; C Capella; C M P Duke; S Dewhurst
Journal:  J Appl Microbiol       Date:  2007-05       Impact factor: 3.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.